Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

EMA to undergo significant reorganisation in 2013 to support its scientific committees

This article was originally published in SRA

  • News

Executive Summary

The European Medicines Agency is reviewing its operations and processes to increase the efficiency of its scientific activities and IT operations. The process is expected to result in a significant reorganisation of agency personnel in 2013 and a reduction in the number of staff members contributing to external meeting and forums at least until spring1.

Table

View full table

Tags:
Latest Headlines

EU Launches Critical Medicines Alliance But Prospect Of Act On Manufacturing Still Uncertain

‘Shocking’ MHRA Performance & Poor Data Transparency Blamed For UK’s Clinical Trial Crisis

Updated COVID-19 Vaccines Should Target New JN.1 Variant, Says EMA

EMA Pilots Partnering With Companies To Gain Efficiencies In Preparing Drug Assessment Reports

See All
UsernamePublicRestriction

Register

PS117093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By